PP
ABBV icon

Peconic Partners’s AbbVie ABBV Stock Holding History

Peconic Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,000
Closed -$2.39M – 18
2023
Q1 		$2.39M Hold
15,000
– – 0.14% 13
2022
Q4 		$2.42M Hold
15,000
– – 0.16% 13
2022
Q3 		$2.01M Buy
+15,000
New +$2.15M 0.14% 15
2020
Q1 		– Sell
-10,000
Closed -$885K – 52
2019
Q4 		$885K Hold
10,000
– – 0.18% 29
2019
Q3 		$757K Buy
+10,000
New +$686K 0.18% 28

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Peconic Partners's ABBV Position: Q2 2023 in Review

Peconic Partners sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 15,000 shares — an estimated $2.39M sold.

Peconic Partners first reported a position in ABBV in Q3 2019 and held it in 5 quarters. The position peaked at $2.42M in Q4 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Peconic Partners reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Peconic Partners sold 15,000 AbbVie shares in Q2 2023, an estimated $2.39M.
  • Peconic Partners first reported a position in AbbVie in Q3 2019 and held it in 5 quarters.
  • Peconic Partners's AbbVie position peaked at $2.42M in Q4 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Peconic Partners's 13F filing for Q2 2023, filed 14 Aug 2023.